IV acetaminophen
Drug1 gram every 6 hours
NCT Number: NCT02804633
The investigators hypothesis is that use of IV acetaminophen will significantly decrease use of post-operative opioid consumption and enhances recovery after colorectal surgery.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
All patients undergoing laparoscopic and open colorectal surgery are randomized to receive either IV acetaminophen or placebo. All patients received an opioid patient controlled anesthesia (PCA). IV acetaminophen (1 gram) or placebo is given 30 minutes prior to operation and every 6 hours thereafter for up to 5 days post-operatively or discharge.
The investigators primary endpoint is to evaluate opioid consumption during the patient's hospital stay. The investigators secondary endpoints are to evaluate return of gastrointestinal function (ROGIF), time to diet ordered (TTDO), length of hospital stay (LOHS) and occurrence of ileus. Pain is measured with the pain visual analog scale score (PVASS) at 3, 8, 24 and 48 hours.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1 gram every 6 hours
100 ml of normal saline every 6 hours
Time frame: 48 hours
Time frame: 48 hours
Time frame: through study completion, an average of 5 days
Time frame: through study completion, an average of 5 days
Time frame: through study completion, an average of 5 days
Time frame: through study completion, an average of 5 days
Jewish Hospital, Cincinnati, Ohio
Other
Decreased Opioid Consumption and Enhance Recovery With the Addition of IV-Acetaminophen in Colorectal Patients: A Prospective, Randomized, Double-Blinded, Placebo-Controlled Study
Acronym: DOCIVA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04401007
Agnosia, Nervous System Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT07736118
Agnosia, Behavior
Kayseri, Turkey (Türkiye)
View Trial DetailsNCT07145788
Agnosia, Chronic Pain
Stuttgart, Auerbachstraße 112, Germany
View Trial DetailsNCT05506878
Abdominal Pain, Agnosia
Pittsburgh, Pennsylvania, United States
View Trial Details